News GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:12 2025-05-22 am EDT			5-day change	1st Jan Change
1,428.50 ^GBX	-0.10%		+4.84%	+6.09%

11:17pm	US FDA Approves GSK's Add-on Maintenance for Chronic Obstructive Pulmonary Disease	MT
May. 22	GSK plc Announces US Food and Drug Administration Approves Nucala (Mepolizumab) for Use in Adults with Chronic Obstructive Lung Disease	CI

UK Stocks-Factors to watch on May 23	01:22am	RE
US FDA Approves GSK's Add-on Maintenance for Chronic Obstructive Pulmonary Disease	11:17pm	MT
Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)	May. 22	BU
GSK plc Announces US Food and Drug Administration Approves Nucala (Mepolizumab) for Use in Adults with Chronic Obstructive Lung Disease	May. 22	CI
GSK Gets FDA Approval for Mepolizumab Use in Adult COPD Patients	May. 22	MT
GSK's asthma drug wins FDA approval to treat 'smoker's lung'	May. 22	RE
GSK's asthma drug wins FDA approval to treat 'smoker's lung'	May. 22	RE
GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'	May. 22	RE
GSK Says Nucala Approved By US FDA For Use In Adults With COPD	May. 22	RE
GSK : Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)	May. 22	PU
AlphaValue/Baader Europe Cuts GSK's Price Target on Pipeline, Patent Concerns	May. 22	MT
US CDC accepts recommendations for chikungunya vaccines	May. 21	RE
US CDC approves recommendations for chikungunya vaccines	May. 21	RE
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading	May. 21	MT
GSK PLC : Despite its challenges, GSK remains investable	May. 21
Curevac Q1 Revenue Eur 900 Thousand	May. 20	RE
GSK's Blood-Cancer Treatment Combinations Approved in Japan	May. 19	DJ
European Equities Close Mixed in Monday Trading; Annual Inflation Declines in EU, Flat in Euro Area	May. 19	MT
British Equities Start Week Higher Amid UK-EU Trade Deal	May. 19	MT
Global markets live: Nvidia, Novavax, Diageo, GSK, Vodacom…	May. 19
GSK plc Announces Approval Ofenrep Combinations by Japan's Ministry of Health, Labour and Welfare for the Treatment of Adults with Relapsed/Refractory Multiple Myeloma	May. 19	CI
23andMe's journey from DNA testing pioneer to bankruptcy sale	May. 19	RE
GSK Says Blenrep Combinations Approved in Japan for Relapsed, Refractory Multiple Myeloma	May. 19	MT
GSK: Japan gives green light to Blenrep for myeloma	May. 19	CF
GSK wins approval in Japan for Blenrep combination as myeloma therapy	May. 19	AN